[Compliance with biologic agents: Current situation].
L’observance des biothérapies : état des lieux.
Adherence
Adhésion
Biologic agents
Biothérapie
Compliance
Education
Éducation
Journal
Revue des maladies respiratoires
ISSN: 1776-2588
Titre abrégé: Rev Mal Respir
Pays: France
ID NLM: 8408032
Informations de publication
Date de publication:
Sep 2021
Sep 2021
Historique:
received:
16
02
2021
accepted:
14
04
2021
pubmed:
19
6
2021
medline:
18
9
2021
entrez:
18
6
2021
Statut:
ppublish
Résumé
Despite the fact that the prognosis of chronic inflammatory disorders is improved by biological agents, compliance with those therapeutics remains imperfect. Compliance corresponds to the measurable part of the follow-up of the medical prescription by the patient, whereas adherence is related to the acceptation of the treatment by the patient. The compliance rates of biologic agents are generally higher than those of conventional therapies. Compliance can be influenced by the real or experienced efficacity of the treatment, by patient-related factors or by the patient-physician relationship. An increase of compliance is associated with an improvement of adherence. To achieve this, the physician can use educational measures such as patient education, which allows the identification of poor adherence. Such programs have been shown to improve the patient's knowledge of the disease and treatment leading to better adherence and compliance.
Identifiants
pubmed: 34140211
pii: S0761-8425(21)00302-8
doi: 10.1016/j.rmr.2021.06.001
pii:
doi:
Substances chimiques
Biological Factors
0
Types de publication
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
698-705Informations de copyright
Copyright © 2021 SPLF. Published by Elsevier Masson SAS. All rights reserved.